NeOnc Technologies Holdings, Inc. (NTHI) stock
NTHINasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.48−0.68 (-16.35%)
Close on Nov 19, 2026Market cap $90.26MP/E –Yield –
NeOnc Technologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
NeOnc Technologies's operating income for the twelve months ending Sep 30, 2026 was -$40.66M. For fiscal 2025 it was -$58.24M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$58.24M | – |
| FY2024 | Dec 31, 2024 | -$7.14M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$5.83M | – |
| Q2 FY2026 | Jun 30, 2026 | -$14.07M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.06M | – |
| Q4 FY2025 | Dec 31, 2025 | -$13.70M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.93M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.71M | – |
| Q1 FY2025 | Mar 31, 2025 | -$31.90M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.11M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.20M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.55M | – |
See a number that looks wrong?